OFIX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
210.9M
+7.2%
196.7M
-10.6%
219.9M
+6.9%
205.6M
+1.2%
203.1M
Cost of Revenue
61.2M
+7.1%
57.2M
-10.1%
63.6M
+11.3%
57.1M
-10.2%
63.6M
Gross Profit
149.7M
+7.3%
139.5M
-10.7%
156.3M
+5.3%
148.5M
+6.4%
139.5M
Operating Expenses
157.8M
+2.5%
154.0M
-1.2%
155.8M
-5.9%
165.6M
+6.5%
155.5M
R&D
15.9M
+4.1%
15.3M
-0.3%
15.4M
+4.1%
14.8M
-7.3%
15.9M
SG&A
138.0M
+2.3%
134.9M
-1.3%
136.8M
-7.7%
148.1M
+8.5%
136.5M
Operating Income
-8134000
+43.7%
-14436000
-3022.3%
494.0K
+102.9%
-17046000
-6.5%
-16003000
EBITDA
9.0M
+220.7%
2.8M
-83.8%
17.3M
+1324.8%
-1412000
-135.5%
4.0M
Net Income
-15798000
+24.4%
-20908000
-841.0%
-2222000
+90.3%
-22795000
-61.9%
-14081000
EPS (Basic)
$-0.39
+25.0%
$-0.52
-766.7%
$-0.06
+89.5%
$-0.57
-58.3%
$-0.36
EPS (Diluted)
$-0.39
+25.0%
$-0.52
-766.7%
$-0.06
+89.5%
$-0.57
-58.3%
$-0.36
Shares (Diluted)
40.9M
+1.1%
40.5M
+1.2%
40.0M
+0.5%
39.8M
+0.7%
39.5M
Orthofix Medical Inc. (DE) (OFIX) โ€” Financials